Business
AstraZeneca COVID-19 vaccine faces regulatory hurdles as Novavax releases both ‘encouraging’ and ‘concerning’ results – ABC News
European regulatory bodies are questioning the lack of data supplied for the Oxford-AstraZeneca vaccine, recommending against its use for the elderly, as another…
Experts say the problems associated with “first-generation” COVID-19 vaccines are being exposed, as one European regulatory body questions the lack of data supplied for the Oxford-AstraZeneca vaccine and recommends against its use for the elderly.
Key points:
- European regulatory bodies are concerned over the lack of data for the elderly during trials of the Oxford-AstraZeneca vaccine
- The TGA, described as “the best regulator in the world” by the Health Minister, is expected to make a decision in…
Continue Reading
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General17 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
General23 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers